IGFBP5 (insulin like growth factor binding protein 5) is epigenetically silenced by H3K27me3 in advanced atherosclerotic plaques, suggesting that targeting the H3K27me3/IGFBP5 pathway may provide novel therapeutics for atherosclerosis (Xu et al., 2018). The gene discussed is IGFBP5; the disease is atherosclerosis.